HYD Stock Overview
Provides product design, engineering, and regulatory consulting services in Australia, Singapore, Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Hydrix Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.01 |
| 52 Week High | AU$0.024 |
| 52 Week Low | AU$0.01 |
| Beta | 1.7 |
| 11 Month Change | -16.67% |
| 3 Month Change | -16.67% |
| 1 Year Change | -52.38% |
| 33 Year Change | -92.31% |
| 5 Year Change | -96.30% |
| Change since IPO | -99.80% |
Recent News & Updates
Shareholder Returns
| HYD | AU Electronic | AU Market | |
|---|---|---|---|
| 7D | -9.1% | -1.0% | 1.5% |
| 1Y | -52.4% | 5.4% | 17.2% |
Return vs Industry: HYD underperformed the Australian Electronic industry which returned 6.7% over the past year.
Return vs Market: HYD underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
| HYD volatility | |
|---|---|
| HYD Average Weekly Movement | 12.5% |
| Electronic Industry Average Movement | 10.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: HYD's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: HYD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 60 | n/a | www.hydrix.com |
Hydrix Limited provides product design, engineering, and regulatory consulting services in Australia, Singapore, Europe, North America, and internationally. The company operates through three segments: Hydrix Services, Hydrix Medical, and Hydrix Ventures. Its products portfolio comprises The GUARDIAN, a cardiac monitoring device that alerts and warns patients to seek medical attention for acute coronary syndrome (ACS), including silent heart attacks; LUDO, a platform that develops mechanical circulatory support control systems; EchoSolv, a cloud-based decision support platform, which provides physicians with tools to identify patients at-risk of structural heart disease; and Implicity, an AI-driven RM solution that delivers cardiovascular monitoring technology and data management tools, which supports health professionals in the diagnosis, rehabilitation, and surveillance of cardiovascular patients.
Hydrix Limited Fundamentals Summary
| HYD fundamental statistics | |
|---|---|
| Market cap | AU$2.54m |
| Earnings (TTM) | -AU$9.56m |
| Revenue (TTM) | AU$10.63m |
0.2x
P/S Ratio-0.3x
P/E RatioIs HYD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYD income statement (TTM) | |
|---|---|
| Revenue | AU$10.63m |
| Cost of Revenue | AU$819.56k |
| Gross Profit | AU$9.81m |
| Other Expenses | AU$19.37m |
| Earnings | -AU$9.56m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.038 |
| Gross Margin | 92.29% |
| Net Profit Margin | -89.92% |
| Debt/Equity Ratio | -159.5% |
How did HYD perform over the long term?
See historical performance and comparison